CIK 0001253689 · Non-accelerated filer<br>Smaller reporting company
CRESCENT BIOPHARMA, INC.
Sign in to watch- Ticker
- CBIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Cayman Islands
- Entity type
- operating
- Phone
- 617-430-5595
- Business address
- 300 FIFTH AVENUE, WALTHAM, MA, 02451
- Former names
- GLYCOMIMETICS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $285,501
- in 7 filings, $286K under 10b5-1 plans
Net −$285,501. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Brumm Joshua T −$160K Chief Executive Officer sold 3% of stake
- McNeill Jonathan −$77K President and COO sold 3% of stake
- Pinkas Jan −$12K Chief Scientific Officer sold 3% of stake
- Im Ellie Eunkyung −$11K Chief Medical Officer sold 3% of stake
- Bispham Barbara Harlin −$11K See Remarks sold 3% of stake
Reading 48 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2016-05-17 | BARRETT M JAMES Director | Grant or award · Stock Option (right to buy) | +11,000 | 11,000 | ||
| 2016-05-17 | JUNIUS DANIEL M Director | Grant or award · Stock Option (right to buy) | +11,000 | 11,000 | ||
| 2016-05-17 | TOP FRANKLIN H JR Director | Grant or award · Stock Option (right to buy) | +11,000 | 11,000 | ||
| 2016-05-17 | PEARSON TIMOTHY R Director | Grant or award · Stock Option (right to buy) | +11,000 | 11,000 | ||
| 2016-05-17 | Goldberg Mark Alan Director | Grant or award · Stock Option (right to buy) | +11,000 | 11,000 |
Page 16 of 16 · 305 trades